Search
for
Sort by
Research 661–690 of 1000+
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Tricorrexis nodosa localizada
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Poster Abstracts
- Il-10 family members as novel responders to genotoxic stress
- Evaluation of Coronary Sinus Strain in Patients with Dipper and Non-Dipper Hypertension
- Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Prevalence of polycystic ovary syndrome in unselected women from southern China
- Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women
- Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Assessing diagnostic skill in dermatology: A comparison between general practitioners and dermatologists
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Alefacept for Severe Alopecia Areata
- Topical valproic acid increases the hair count in male patients with androgenetic alopecia: A randomized, comparative, clinical feasibility study using phototrichogram analysis
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Correction of the High Female Hairline
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- 2% Topical Minoxidil Solution in Male-Pattern Baldness: Preliminary European Results
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994–96)
- Fabrication of polyvinyl pyrrolidone-K90/Eudragit RL100-based dissolving microneedle patches loaded with alpha-arbutin and resveratrol for skin depigmentation
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Controversies in the treatment of androgenetic alopecia: The history of finasteride